Meridian Medical Technologies Seeks DEA Approval for Morphine Importation
March 13, 2025
March 13, 2025
WASHINGTON, March 13 (TNSFR) -- Meridian Medical Technologies, LLC, a pharmaceutical company based in Saint Louis, Missouri, has applied for registration with the Drug Enforcement Administration (DEA) as an importer of Morphine, a Schedule II controlled substance.
The company, located at 2555 Hermelin Drive, has stated that the importation will be strictly for analytical purposes, ensuring that the substance is used solely for research and testing rather than for distribution or co . . .
The company, located at 2555 Hermelin Drive, has stated that the importation will be strictly for analytical purposes, ensuring that the substance is used solely for research and testing rather than for distribution or co . . .